1 |
1) inosine 5'-monophosphate |
Inosine |
1件: D00054 D00054 💬 |
- |
- |
017 1件: 17 💬 |
2 |
1-(2-isopropoxyethyl)-2-thioxo-1,2,3,5-tetrahydro-pyrrolo[3,2-d] pyrimidin-4-one |
- |
- |
- |
- |
017 1件: 17 💬 |
3 |
11c-methylreboxetine |
- |
- |
- |
- |
006 2件: 6 , 17 💬 |
4 |
13n-ammonia |
Ammonia |
1件: D02916 D02916 💬 |
- |
- |
006 2件: 6 , 17 💬 |
5 |
18f-dopa |
- |
- |
- |
- |
006 3件: 6 , 17, 75 💬 |
6 |
18f-dopamne |
- |
- |
- |
- |
006 2件: 6 , 17 💬 |
7 |
[18f]fdopa |
- |
- |
- |
- |
006 2件: 6 , 17 💬 |
8 |
[f-18]pbr06 |
- |
- |
- |
- |
013 2件: 13, 17 💬 |
9 |
Adjuvant without active component |
- |
- |
- |
- |
006 2件: 6 , 17 💬 |
10 |
Affitope® pd01a + adjuvant |
- |
- |
- |
- |
006 2件: 6 , 17 💬 |
11 |
Affitope® pd03a + adjuvant |
- |
- |
- |
- |
017 1件: 17 💬 |
12 |
Ammonia |
Ammonia |
1件: D02916 D02916 💬 |
- |
- |
006 4件: 6 , 17, 86, 88 💬 |
13 |
Ampreloxetine |
Ampreloxetine |
1件: D11688 D11688 💬 |
SLC6A2 2件: SLC6A2, SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 2件: 6 , 17 💬 |
14 |
Ampreloxetine chydrochloride |
Ampreloxetine |
1件: D11688 D11688 💬 |
SLC6A2 2件: SLC6A2, SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 2件: 6 , 17 💬 |
15 |
Ampreloxetine hydrochloride |
Ampreloxetine |
1件: D11688 D11688 💬 |
SLC6A2 2件: SLC6A2, SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 2件: 6 , 17 💬 |
16 |
Angiotensin |
Angiotensin II |
2件: D00150 D00150, D02014 D02014 💬 |
AGTR1 2件: AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 7件: 17, 19, 46, 66, 86, 222, 224 💬 |
17 |
Angiotensin-(1-7) |
Angiotensin II |
2件: D00150 D00150, D02014 D02014 💬 |
AGTR1 2件: AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 1件: 17 💬 |
18 |
Anti-parkinson medication |
- |
- |
- |
- |
005 5件: 5 , 6 , 7 , 8 , 17 💬 |
19 |
Atomexetine |
- |
- |
- |
- |
017 1件: 17 💬 |
20 |
Autologous mesenchymal stem cells |
- |
- |
- |
- |
002 5件: 2 , 6 , 13, 17, 46 💬 |
21 |
Azd3241 |
- |
- |
- |
- |
006 2件: 6 , 17 💬 |
22 |
Azd3241 100mg |
- |
- |
- |
- |
017 1件: 17 💬 |
23 |
Azd3241 300mg |
- |
- |
- |
- |
017 1件: 17 💬 |
24 |
Azilect |
- |
- |
- |
- |
002 4件: 2 , 5 , 6 , 17 💬 |
25 |
Azilect 1 mg comprimidos |
- |
- |
- |
- |
006 2件: 6 , 17 💬 |
26 |
Behavioral: bci-fit active querying |
- |
- |
- |
- |
002 3件: 2 , 6 , 17 💬 |
27 |
Behavioral: bci-fit adaptive signal modeling |
- |
- |
- |
- |
002 3件: 2 , 6 , 17 💬 |
28 |
Behavioral: bci-fit language modeling |
- |
- |
- |
- |
002 3件: 2 , 6 , 17 💬 |
29 |
Behavioral: bci-fit multi-modal access |
- |
- |
- |
- |
002 3件: 2 , 6 , 17 💬 |
30 |
Behavioral: clinical characteristics of ams patients |
- |
- |
- |
- |
017 1件: 17 💬 |
31 |
Behavioral: conservative measures for orthostatic hypotension |
- |
- |
- |
- |
006 2件: 6 , 17 💬 |
32 |
Behavioral: montreal cognitive assessment (moca) |
- |
- |
- |
- |
017 1件: 17 💬 |
33 |
Bhv-3241 |
- |
- |
- |
- |
017 1件: 17 💬 |
34 |
Bhv-4157 |
- |
- |
- |
- |
017 1件: 17 💬 |
35 |
Biib101 |
- |
- |
- |
- |
017 1件: 17 💬 |
36 |
Blood sampling |
- |
- |
- |
- |
013 5件: 13, 17, 19, 51, 96 💬 |
37 |
Botulinum toxin type a |
Botulinum toxin type A |
1件: D00783 D00783 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
002 10件: 2 , 5 , 6 , 7 , 13, 15, 17, 70, 113, 149 💬 |
38 |
Bq123 |
- |
- |
- |
- |
017 1件: 17 💬 |
39 |
Bydureon |
- |
- |
- |
- |
006 2件: 6 , 17 💬 |
40 |
Captopril |
Captopril |
1件: D00251 D00251 💬 |
ACE 1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
017 2件: 17, 86 💬 |
41 |
Carbidopa |
Carbidopa |
1件: D00558 D00558 💬 |
DDC 1件: DDC 💬 |
Alcoholism 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 9件: 2 , 4 , 6 , 13, 17, 90, 140, 164, 201 💬 |
42 |
Carbidopa 200mg oral dose |
Carbidopa |
1件: D00558 D00558 💬 |
DDC 1件: DDC 💬 |
Alcoholism 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 2件: 6 , 17 💬 |
43 |
Carbonate |
Carbonate ion |
- |
- |
- |
002 12件: 2 , 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 💬 |
44 |
Cs10br05 |
- |
- |
- |
- |
017 1件: 17 💬 |
45 |
Datscan |
- |
- |
- |
- |
002 4件: 2 , 5 , 6 , 17 💬 |
46 |
Datscan™ ioflupane (123i) injection |
- |
- |
- |
- |
005 3件: 5 , 6 , 17 💬 |
47 |
Desipramine |
Desipramine |
2件: D00812 D00812, D07791 D07791 💬 |
SLC6A2 2件: SLC6A2, SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 4件: 6 , 17, 120, 156 💬 |
48 |
Desipramine (dmi) |
Desipramine |
2件: D00812 D00812, D07791 D07791 💬 |
SLC6A2 2件: SLC6A2, SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 2件: 6 , 17 💬 |
49 |
Device: abdominal compression |
- |
- |
- |
- |
006 2件: 6 , 17 💬 |
50 |
Device: deep brain stimulation |
- |
- |
- |
- |
005 5件: 5 , 6 , 7 , 8 , 17 💬 |
51 |
Device: sham compression |
- |
- |
- |
- |
006 2件: 6 , 17 💬 |
52 |
Diagnostic test: [18f]-ro6958948 |
- |
- |
- |
- |
005 5件: 5 , 6 , 7 , 17, 127 💬 |
53 |
Diagnostic test: elecsys (roche) abeta42, ttau and ptau |
- |
- |
- |
- |
005 5件: 5 , 6 , 7 , 17, 127 💬 |
54 |
Diagnostic test: flutemetamol f18 injection |
Flutemetamol |
1件: D10231 D10231 💬 |
- |
- |
005 5件: 5 , 6 , 7 , 17, 127 💬 |
55 |
Diagnostic test: lumipulse (fujirebio) abeta42, ttau and ptau |
- |
- |
- |
- |
005 5件: 5 , 6 , 7 , 17, 127 💬 |
56 |
Dmi |
- |
- |
- |
- |
006 2件: 6 , 17 💬 |
57 |
Domperidone |
Domperidone |
2件: D01745 D01745, D07868 D07868 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 5件: 6 , 13, 17, 51, 230 💬 |
58 |
Dops |
Droxidopa |
1件: D01277 D01277 💬 |
ADRA1A 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 2件: 6 , 17 💬 |
59 |
Droxidopa |
Droxidopa |
1件: D01277 D01277 💬 |
ADRA1A 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
005 3件: 5 , 6 , 17 💬 |
60 |
Egcg |
Epigallocatechin gallate |
- |
- |
- |
006 9件: 6 , 8 , 13, 17, 28, 85, 113, 206, 299 💬 |
61 |
Egcg as putative neuroprotective agent |
Epigallocatechin gallate |
- |
- |
- |
017 1件: 17 💬 |
62 |
Emeramide |
Emeramide |
- |
- |
- |
005 2件: 5 , 17 💬 |
63 |
Entacapone |
Entacapone |
1件: D00781 D00781 💬 |
COMT 1件: COMT 💬 |
Dopaminergic synapse 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism |
006 2件: 6 , 17 💬 |
64 |
Entacapone 400mg oral dose |
Entacapone |
1件: D00781 D00781 💬 |
COMT 1件: COMT 💬 |
Dopaminergic synapse 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism |
006 2件: 6 , 17 💬 |
65 |
Exenatide |
Exenatide |
1件: D04121 D04121 💬 |
GLP1R 1件: GLP1R 💬 |
Insulin secretion 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 4件: 6 , 17, 193, 233 💬 |
66 |
Exenatide pen injector [bydureon] |
Exenatide |
1件: D04121 D04121 💬 |
GLP1R 1件: GLP1R 💬 |
Insulin secretion 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
017 1件: 17 💬 |
67 |
Fipamezole |
Fipamezole |
- |
- |
- |
006 2件: 6 , 17 💬 |
68 |
Fipamezole hydrochloride |
Fipamezole |
- |
- |
- |
006 2件: 6 , 17 💬 |
69 |
Fipamezole hydrochloride 30 mg oral disintegrating tablets |
Fipamezole |
- |
- |
- |
006 2件: 6 , 17 💬 |
70 |
Fipamezole hydrochloride 60 mg oral disintegrating tablets |
Fipamezole |
- |
- |
- |
006 2件: 6 , 17 💬 |
71 |
Fipamezole hydrochloride 90 mg oral disintegrating tablets |
Fipamezole |
- |
- |
- |
006 2件: 6 , 17 💬 |
72 |
Fludrocortisone |
Fludrocortisone |
2件: D00986 D00986, D07967 D07967 💬 |
NR3C2 1件: NR3C2 💬 |
Aldosterone-regulated sodium reabsorption 1件: Aldosterone-regulated sodium reabsorption |
006 3件: 6 , 17, 81 💬 |
73 |
Flumazenil |
Flumazenil |
1件: D00697 D00697 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 5件: 6 , 13, 17, 18, 206 💬 |
74 |
Fluoxetine |
Fluoxetine |
2件: D00326 D00326, D00823 D00823 💬 |
SLC6A4 1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
013 4件: 13, 17, 78, 86 💬 |
75 |
Fluoxétine |
Fluoxetine |
2件: D00326 D00326, D00823 D00823 💬 |
SLC6A4 1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
017 1件: 17 💬 |
76 |
Flutemetamol |
Flutemetamol |
- |
- |
- |
005 5件: 5 , 6 , 7 , 17, 127 💬 |
77 |
Flutemetamol f18 |
Flutemetamol |
1件: D10231 D10231 💬 |
- |
- |
005 5件: 5 , 6 , 7 , 17, 127 💬 |
78 |
Gold |
Gold |
- |
- |
- |
002 38件: 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
79 |
Green tea |
Green tea leaf |
1件: D06903 D06903 💬 |
- |
- |
006 5件: 6 , 17, 28, 46, 96 💬 |
80 |
Green tea leaf |
Green tea leaf |
1件: D06903 D06903 💬 |
- |
- |
017 1件: 17 💬 |
81 |
Homeostasis model assessment of insulin resistance (homa) |
- |
- |
- |
- |
017 1件: 17 💬 |
82 |
Hydrogen |
Hydrogen |
- |
- |
- |
005 7件: 5 , 6 , 13, 17, 83, 97, 226 💬 |
83 |
Inosine |
Inosine |
1件: D00054 D00054 💬 |
- |
- |
002 4件: 2 , 6 , 13, 17 💬 |
84 |
Intranasal insulin |
- |
- |
- |
- |
006 2件: 6 , 17 💬 |
85 |
Intravenous immunoglobulin (ivig) |
Human immunoglobulin G |
- |
- |
- |
014 4件: 14, 17, 164, 296 💬 |
86 |
Intravesical injection of botulinum a toxin |
- |
- |
- |
- |
006 2件: 6 , 17 💬 |
87 |
Iupac name: 1-(2-isopropoxyethyl)-2-thioxo-1,2,3,5-tetrahydro-pyrrolo[3,2-d] pyrimidin-4-one |
- |
- |
- |
- |
017 1件: 17 💬 |
88 |
Ivig |
Human immunoglobulin G |
- |
- |
- |
011 8件: 11, 13, 14, 17, 35, 50, 51, 65 💬 |
89 |
Jp-1730/f01 |
- |
- |
- |
- |
006 2件: 6 , 17 💬 |
90 |
Jp-1730/f02 |
- |
- |
- |
- |
006 2件: 6 , 17 💬 |
91 |
Jp-1730/f03 |
- |
- |
- |
- |
006 2件: 6 , 17 💬 |
92 |
L-threo dops |
Droxidopa |
1件: D01277 D01277 💬 |
ADRA1A 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 1件: 17 💬 |
93 |
Levodopa |
Levodopa |
1件: D00059 D00059 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 8件: 2 , 4 , 6 , 17, 90, 140, 164, 201 💬 |
94 |
Levodopa test |
Levodopa |
1件: D00059 D00059 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
017 1件: 17 💬 |
95 |
Lithium carbonate |
Carbonate ion |
1件: D00801 D00801 💬 |
- |
- |
002 6件: 2 , 13, 17, 18, 19, 127 💬 |
96 |
Litio carbonato |
- |
- |
- |
- |
002 2件: 2 , 17 💬 |
97 |
Losartan |
Losartan |
2件: D00357 D00357, D08146 D08146 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
98 |
Metoprolol |
Metoprolol |
3件: D00601 D00601, D02358 D02358, D05011 D05011 💬 |
ADRB1 1件: ADRB1 💬 |
Adrenergic signaling in cardiomyocytes 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 6件: 17, 57, 58, 113, 193, 226 💬 |
99 |
Metoprolol tartrate 50 mg |
Metoprolol |
3件: D00601 D00601, D02358 D02358, D05011 D05011 💬 |
ADRB1 1件: ADRB1 💬 |
Adrenergic signaling in cardiomyocytes 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 1件: 17 💬 |
100 |
Midodrine |
Midodrine |
2件: D01307 D01307, D08220 D08220 💬 |
ADRA1A 3件: ADRA1A, ADRA1B, ADRA1D 💬 |
AMPK signaling pathway 7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
006 3件: 6 , 17, 58 💬 |
101 |
Modal |
- |
- |
- |
- |
002 5件: 2 , 6 , 17, 46, 70 💬 |
102 |
N1,n3-bis(2-mercaptoethyl) isophthalamide |
- |
- |
- |
- |
005 2件: 5 , 17 💬 |
103 |
Nbmi |
- |
- |
- |
- |
005 2件: 5 , 17 💬 |
104 |
Nebivolol |
Nebivolol |
1件: D05127 D05127 💬 |
ADRB1 1件: ADRB1 💬 |
Adrenergic signaling in cardiomyocytes 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 3件: 17, 113, 167 💬 |
105 |
Nebivolol 5 mg |
Nebivolol |
1件: D05127 D05127 💬 |
ADRB1 1件: ADRB1 💬 |
Adrenergic signaling in cardiomyocytes 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 1件: 17 💬 |
106 |
Nitrogen |
Nitrogen |
1件: D00083 D00083 💬 |
- |
- |
005 6件: 5 , 6 , 17, 171, 211, 299 💬 |
107 |
Normal saline |
- |
- |
- |
- |
006 16件: 6 , 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 276, 296, 299 💬 |
108 |
Nt 101 |
- |
- |
- |
- |
005 4件: 5 , 6 , 7 , 17 💬 |
109 |
Other: abdominal compression |
- |
- |
- |
- |
017 1件: 17 💬 |
110 |
Other: brain mri (magnetic resonance imaging) |
- |
- |
- |
- |
017 1件: 17 💬 |
111 |
Other: sham abdominal compression |
- |
- |
- |
- |
017 1件: 17 💬 |
112 |
Procedure: brain magnetic resonance imaging (mri) |
- |
- |
- |
- |
017 1件: 17 💬 |
113 |
Procedure: determination of objective and subjective pain threshold |
- |
- |
- |
- |
017 1件: 17 💬 |
114 |
Prozac |
- |
- |
- |
- |
017 1件: 17 💬 |
115 |
Pseudoephedrine |
Pseudoephedrine |
4件: D00485 D00485, D05648 D05648, D05649 D05649, D08449 D08449 💬 |
ADRA1A 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 1件: 17 💬 |
116 |
Pseudoephedrine + 480 ml water |
Pseudoephedrine |
5件: D00001 D00001, D00485 D00485, D05648 D05648, D05649 D05649, D08449 D08449 💬 |
ADRA1A 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 1件: 17 💬 |
117 |
Pseudoephedrine + 50 ml water |
Pseudoephedrine |
5件: D00001 D00001, D00485 D00485, D05648 D05648, D05649 D05649, D08449 D08449 💬 |
ADRA1A 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 1件: 17 💬 |
118 |
Raclopride |
Raclopride |
- |
- |
- |
005 4件: 5 , 6 , 7 , 17 💬 |
119 |
Radiation: h215o pet |
- |
- |
- |
- |
006 2件: 6 , 17 💬 |
120 |
Radiation: pet (positron emission tomography) study |
- |
- |
- |
- |
017 1件: 17 💬 |
121 |
Rasagilina |
Rasagiline |
3件: D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB 1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 2件: 6 , 17 💬 |
122 |
Rasagilina mesilato |
Rasagiline |
3件: D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB 1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 2件: 6 , 17 💬 |
123 |
Rasagiline |
Rasagiline |
3件: D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB 1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 4件: 2 , 5 , 6 , 17 💬 |
124 |
Rasagiline mesylate |
Rasagiline |
3件: D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB 1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 2件: 6 , 17 💬 |
125 |
Rifampicin |
Rifampicin |
1件: D00211 D00211 💬 |
- |
- |
006 5件: 6 , 17, 46, 93, 299 💬 |
126 |
Riluzole |
Riluzole |
1件: D00775 D00775 💬 |
GRIA1 14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 8件: 2 , 3 , 5 , 8 , 13, 17, 18, 206 💬 |
127 |
Rituximab |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
011 47件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
128 |
Safinamide |
Safinamide |
1件: D10158 D10158 💬 |
MAOB 1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 2件: 6 , 17 💬 |
129 |
Safinamide methanesulfonate |
Safinamide |
1件: D10158 D10158 💬 |
MAOB 1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 2件: 6 , 17 💬 |
130 |
Saline |
- |
- |
- |
- |
006 10件: 6 , 13, 17, 53, 67, 78, 86, 97, 168, 299 💬 |
131 |
Sildenafil25 mg |
- |
- |
- |
- |
017 1件: 17 💬 |
132 |
Sirolimus |
Sirolimus |
1件: D00753 D00753 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
006 35件: 6 , 13, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 💬 |
133 |
Sirolimus 2 mg |
Sirolimus |
1件: D00753 D00753 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
017 1件: 17 💬 |
134 |
Sunphenon egcg |
Epigallocatechin gallate |
- |
- |
- |
013 3件: 13, 17, 113 💬 |
135 |
Td-9855 |
- |
- |
- |
- |
006 2件: 6 , 17 💬 |
136 |
Tea leaf |
Tea leaf |
- |
- |
- |
017 1件: 17 💬 |
137 |
Tllsh2910 |
- |
- |
- |
- |
017 1件: 17 💬 |
138 |
Trimethaphan |
Trimethaphan |
1件: D00612 D00612 💬 |
CHRNA10 1件: CHRNA10 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
017 1件: 17 💬 |
139 |
Ubiquinol |
Ubiquinol |
- |
- |
- |
006 3件: 6 , 8 , 17 💬 |
140 |
Verdiperstat |
Verdiperstat |
1件: D11684 D11684 💬 |
MPO 1件: MPO 💬 |
Acute myeloid leukemia 5件: Acute myeloid leukemia, Drug metabolism - other enzymes, Neutrophil extracellular trap formation, Phagosome, Transcriptional misregulation in cancer |
002 2件: 2 , 17 💬 |
141 |
Water |
Water |
1件: D00001 D00001 💬 |
- |
- |
002 22件: 2 , 5 , 6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬 |
142 |
Xadago |
- |
- |
- |
- |
006 2件: 6 , 17 💬 |
143 |
Xeomin |
- |
- |
- |
- |
005 7件: 5 , 6 , 7 , 13, 15, 17, 113 💬 |